Oncolytic Herpes Virus Retargeted to HER-2

Cell Cycle - United States
doi 10.4161/cc.8.18.9368
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Inhibition of Human Tumor Growth in Mice by an Oncolytic Herpes Simplex Virus Designed to Target Solely HER-2-positive Cells

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2009English

Tumour-Specific Triple-Regulated Oncolytic Herpes Virus to Target Glioma

Oncotarget
Oncology
2016English

Antitumor Efficacy of 34.5ENVE: A Transcriptionally Retargeted and “Vstat120”-Expressing Oncolytic Virus

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2012English

Oncolytic Herpes Simplex Virus ICP47 Deletion Reverses Tumor Immune Evasion

Yangtze Medicine
2018English

Tumor and Vascular Targeting of a Novel Oncolytic Measles Virus Retargeted Against the Urokinase Receptor

Cancer Research
Cancer ResearchOncology
2009English

Treatment of Breast Cancer Stem Cells With Oncolytic Herpes Simplex Virus

Cancer Gene Therapy
Cancer ResearchMolecular MedicineMolecular Biology
2012English

Synergy of a Herpes Oncolytic Virus and Paclitaxel for Anaplastic Thyroid Cancer

Clinical Cancer Research
Cancer ResearchOncology
2008English

Treatment of Human Hepatocellular Carcinoma by the Oncolytic Herpes Simplex Virus G47delta

Cancer Cell International
Cancer ResearchOncologyGenetics
2014English

A Fusogenic Oncolytic Herpes Simplex Virus for Therapy of Advanced Ovarian Cancer

2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy